Elevated MRPS23 expression facilitates aggressive phenotypes in breast cancer cells
Open Access
- 12 January 2025
- journal article
- Published by CMB Association in Cellular and Molecular Biology
- Vol. 70 (12) , 65-72
Abstract
Mitochondrial ribosomal protein S23 (MRPS23), encoded by a nuclear gene, is a well-known driver of proliferation in cancer. It participates in mitochondrial protein translation, and its expression association has been explored in many types of cancer. However, MRPS23 expression associations are rarely reported in breast cancer (BC). In this study, we explored the MRPS23 expression in BC cells compared with the non-tumoral breast cells. Overexpression and knockdown analysis of MRPS23 were performed in BC cells. Transfection efficiency was evaluated by western blot and qRT-PCR analysis. The role of MRPS23 in the malignant biological behaviors of BC cells was investigated using in-vitro experiments. Our results demonstrate that MRPS23 was aberrantly overexpressed at both the transcript and protein levels in BC cells. Additional findings reveal that deficiency of MRPS23 is associated with a decrease in cell proliferation/viability and compromised cell migration/invasion in BC cells. Relative to the sh-Ctrl group, the expression levels of cadherin, SNAI 1, and TWIST 1 decreased in the MRPS23 knockdown BC cells. We further found a significant decrease in the expression levels of Cyclin D1, Axin 2, LEF1, NKD1, and Survivin in MRPS23 knockdown cells. In conclusion, we found an association between MRPS23 knockdown and the metastasis ability of BC cells. These findings reveal that MRPS23 significantly decreases the migration and invasion of BC, thus inhibiting BC progression. We confirmed for the first time that MRPS23 expression determines the metastasis features of BC. Hence, the findings justify the key role of this protein in BC progression; therefore, it may be a potential therapeutic target for BC therapy.Keywords
This publication has 38 references indexed in Scilit:
- Prevalence of FANCM germline variants in BRCA1/2 negative breast and/or ovarian cancer patients from PakistanFamilial Cancer, 2022
- Cancer statistics for the year 2020: An overviewInternational Journal of Cancer, 2021
- MRPS23 amplification and gene expression in breast cancer; association with proliferation and the non-basal subtypesBreast Cancer Research and Treatment, 2020
- miR-532 promoted gastric cancer migration and invasion by targeting NKD1Life Sciences, 2017
- A mechanically active heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to drive cancer cell invasionNature Cell Biology, 2017
- Cyclin D1, cancer progression, and opportunities in cancer treatmentJournal of Molecular Medicine, 2016
- Chronic p53-independent p21 expression causes genomic instability by deregulating replication licensingNature Cell Biology, 2016
- An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancerNature Genetics, 2014
- Mitochondrial Alterations During Carcinogenesis2013
- Mitochondrial ribosomal protein S36 delays cell cycle progression in association with p53 modification and p21WAF1/CIP1 expressionJournal of Cellular Biochemistry, 2006